NexImmune Q2 EPS $(0.54), Inline

NexImmune (NASDAQ:NEXI) reported quarterly losses of $(0.54) per share which met the analyst consensus estimate.

NexImmune (NASDAQ:NEXI) reported quarterly losses of $(0.54) per share which met the analyst consensus estimate.

Total
0
Shares
Related Posts